HEMISPHERE ENERGY CORP (HME.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:HME - CA4236301020 - Common Stock
1.96 CAD
-0.01 (-0.51%)
HME gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 201 industry peers in the Oil, Gas & Consumable Fuels industry. HME gets an excellent profitability rating and is at the same time showing great financial health properties. HME is valued quite cheap, but it does not seem to be growing. These ratings could make HME a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year HME was profitable.
In the past year HME had a positive cash flow from operations.
Of the past 5 years HME 4 years were profitable.
In the past 5 years HME always reported a positive cash flow from operatings.
1.2 Ratios
HME has a Return On Assets of 24.66%. This is amongst the best in the industry. HME outperforms 97.51% of its industry peers.
With an excellent Return On Equity value of 38.33%, HME belongs to the best of the industry, outperforming 99.00% of the companies in the same industry.
HME's Return On Invested Capital of 31.98% is amongst the best of the industry. HME outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.51%.
The last Return On Invested Capital (31.98%) for HME is well below the 3 year average (38.31%), which needs to be investigated, but indicates that HME had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROIC | 31.98% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
HME's Profit Margin of 30.81% is amongst the best of the industry. HME outperforms 95.02% of its industry peers.
HME's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 42.73%, HME belongs to the top of the industry, outperforming 92.04% of the companies in the same industry.
HME's Operating Margin has improved in the last couple of years.
The Gross Margin of HME (60.82%) is better than 78.11% of its industry peers.
HME's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
Compared to 1 year ago, HME has less shares outstanding
HME has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HME has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.78 indicates that HME is not in any danger for bankruptcy at the moment.
HME has a better Altman-Z score (4.78) than 84.08% of its industry peers.
HME has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
The Debt to FCF ratio of HME (0.07) is better than 96.02% of its industry peers.
HME has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HME (0.03) is better than 74.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Altman-Z | 4.78 |
ROIC/WACC4.06
WACC7.87%
2.3 Liquidity
HME has a Current Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.41, HME is in the better half of the industry, outperforming 70.65% of the companies in the same industry.
A Quick Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
HME has a Quick ratio of 1.41. This is in the better half of the industry: HME outperforms 72.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
The earnings per share for HME have decreased by -9.09% in the last year.
HME shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 80.04% yearly.
HME shows a decrease in Revenue. In the last year, the revenue decreased by -0.77%.
HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.97% yearly.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
HME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -15.87% yearly.
HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.01% yearly.
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 6.53, the valuation of HME can be described as very cheap.
Based on the Price/Earnings ratio, HME is valued cheaply inside the industry as 91.54% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.84. HME is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.32 indicates a rather cheap valuation of HME.
Based on the Price/Forward Earnings ratio, HME is valued cheaply inside the industry as 83.58% of the companies are valued more expensively.
HME is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.53 | ||
| Fwd PE | 7.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HME is valued cheaply inside the industry as 92.04% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HME indicates a rather cheap valuation: HME is cheaper than 98.01% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.25 | ||
| EV/EBITDA | 3.05 |
4.3 Compensation for Growth
HME has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as HME's earnings are expected to decrease with -9.18% in the coming years.
PEG (NY)N/A
PEG (5Y)0.08
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
5. Dividend
5.1 Amount
HME has a Yearly Dividend Yield of 5.08%, which is a nice return.
HME's Dividend Yield is a higher than the industry average which is at 2.95.
HME's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.08% |
5.2 History
HME has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
60.59% of the earnings are spent on dividend by HME. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
TSX-V:HME (12/29/2025, 7:00:00 PM)
1.96
-0.01 (-0.51%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners0.79%
Inst Owner ChangeN/A
Ins Owners15.55%
Ins Owner ChangeN/A
Market Cap185.47M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.47 (26.02%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.08% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.59%
PT rev (3m)5.43%
EPS NQ rev (1m)-18.18%
EPS NQ rev (3m)-25%
EPS NY rev (1m)-3.51%
EPS NY rev (3m)-8.33%
Revenue NQ rev (1m)-11.07%
Revenue NQ rev (3m)-15.47%
Revenue NY rev (1m)-1.77%
Revenue NY rev (3m)-3.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.53 | ||
| Fwd PE | 7.32 | ||
| P/S | 1.89 | ||
| P/FCF | 4.25 | ||
| P/OCF | 3.34 | ||
| P/B | 2.35 | ||
| P/tB | 2.35 | ||
| EV/EBITDA | 3.05 |
EPS(TTM)0.3
EY15.31%
EPS(NY)0.27
Fwd EY13.66%
FCF(TTM)0.46
FCFY23.56%
OCF(TTM)0.59
OCFY29.97%
SpS1.04
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)0.08
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROCE | 42.48% | ||
| ROIC | 31.98% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 43.34% | ||
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% | ||
| FCFM | 44.47% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 105.19% | ||
| Cap/Sales | 12.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.31% | ||
| Profit Quality | 144.34% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 4.78 |
F-Score6
WACC7.87%
ROIC/WACC4.06
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a valuation rating of 8 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the earnings growth outlook for HEMISPHERE ENERGY CORP?
The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -14.17% in the next year.
How sustainable is the dividend of HEMISPHERE ENERGY CORP (HME.CA) stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 4 / 10 and the dividend payout ratio is 60.59%.